Segments (Tables)

6 Months Ended

Jun. 30, 2012

Segments [Abstract]

Schedule of operating segments

	Net Revenues
	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2012			2011			2012			2011
Operating Segment
Home Respiratory Therapy and Home Medical Equipment	$	301,457		$	292,609		$	603,361		$	568,670
Home Infusion Therapy		306,215			283,739			600,024			544,421
Total	$	607,672		$	576,348		$	1,203,385		$	1,113,091
	EBIT
	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2012			2011			2012			2011
Operating Segment
Home Respiratory Therapy and Home Medical Equipment	$	(3,326	)	$	(14,550	)	$	(8,725	)	$	(32,212	)
Home Infusion Therapy		24,691			34,694			44,196			53,104
Total	$	21,365		$	20,144		$	35,471		$	20,892
	Depreciation and Amortization
	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2012			2011			2012			2011
Operating Segment
Home Respiratory Therapy and Home Medical Equipment	$	24,850		$	29,484		$	49,842		$	57,635
Home Infusion Therapy		4,010			4,141			8,384			8,188
Total	$	28,860		$	33,625		$	58,226		$	65,823

Schedule of reconciliation from net (loss) income to EBIT

The following table provides a reconciliation from net loss to EBIT:

	Three Months Ended June 30, 2012								Three Months Ended June 30, 2011
(in thousands)	Home Respiratory Therapy and Home Medical Equipment			Home Infusion Therapy		Total			Home Respiratory Therapy and Home Medical Equipment			Home Infusion Therapy		Total
Net loss						$	(12,736	)						$	(9,437	)
Interest expense, net (a)							33,809								32,984
Income tax expense (benefit)							292								(3,403	)
EBIT	$	(3,326	)	$	24,691	$	21,365		$	(14,550	)	$	34,694	$	20,144

	Six Months Ended June 30, 2012								Six Months Ended June 30, 2011
(in thousands)	Home Respiratory Therapy and Home Medical Equipment			Home Infusion Therapy		Total			Home Respiratory Therapy and Home Medical Equipment			Home Infusion Therapy		Total
Net loss						$	(32,343	)						$	(30,461	)
Interest expense, net (b)							66,624								65,487
Income tax expense (benefit)							1,190								(14,134	)
EBIT	$	(8,725	)	$	44,196	$	35,471		$	(32,212	)	$	53,104	$	20,892

(a) Reflects $33.9 million of interest expense, net of $0.1 million of interest income for the three months ended June 30, 2012. Reflects $33.0 million of interest expense, net of $0.0 million of interest income for the three months ended June 30, 2011.

(b) Reflects $67.4 million of interest expense, net of $0.8 million of interest income for the six months ended June 30, 2012. Reflects $65.9 million of interest expense, net of $0.4 million of interest income for the six months ended June 30, 2011.